Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A pharmaceutical composition, preparation and preparation method for treating epilepsy

A technology of pharmaceutical preparations and compositions, applied in the directions of pharmaceutical combinations, pharmaceutical formulations, and medical preparations containing active ingredients, etc., can solve problems such as emotional response disorders, inability to be cured by western medicine, and strong drug dependence.

Active Publication Date: 2020-10-23
冯玉兴
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine is mostly used to treat epilepsy, but Western medicine cannot cure it, and there are some side effects, such as strong drug dependence, emotional response disorder, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0040] A preparation method of a medicinal preparation for treating epilepsy, comprising: in parts by weight, dragon teeth, calcined oysters, cassia, antelope horns, Gastrodia elata, silkworm, cinnabar, amber, whole insects, centipedes, calamus, The powders of geranium yellow, gallinaceous star, frankincense, myrrh, bezoar, tortoise shell, musk and white snake head are mixed to obtain a powder. Wherein, the particle size of the powder is 10-50 μm.

[0041] Further, it also includes mixing the powder with pharmaceutically acceptable auxiliary materials, drying, and compressing into tablets to obtain pills or tablets. Or the powder is filled in capsules to obtain capsules. Wherein, the pharmaceutically acceptable auxiliary material can be xylitol or glucose. It should be noted that the pharmaceutically acceptable excipients are not limited to xylitol or glucose.

[0042] The preparation method of the pharmaceutical preparation is simple and easy to implement, and has strong o...

Embodiment 1

[0045]This embodiment provides a pharmaceutical preparation for treating epilepsy, which is obtained by grinding the pharmaceutical composition for treating epilepsy into powder and mixing. The pharmaceutical composition comprises: 7g of dragon teeth, 9g of calcined oysters, 10g of Cassia chinensis, 5g of antelope horns, 13g of Gastrodia elata, 8g of silkworms, 5g of cinnabar, 12g of amber, 9g of whole insects, 10g of centipedes, 14g of calamus, 10g of Tianzhuhuang , Dannanxing 4g, frankincense 10g, myrrh 8g, bezoar 1.8g, tortoise shell 8g, musk 0.3g and white snake head 7g.

Embodiment 2

[0047] This embodiment provides a pharmaceutical preparation for treating epilepsy, which is obtained by grinding the pharmaceutical composition for treating epilepsy into powder and mixing. The pharmaceutical composition comprises: 9g of dragon teeth, 8g of calcined oysters, 11g of Cassia chinensis, 6g of antelope horns, 12g of Gastrodia elata, 10g of silkworm, 3g of cinnabar, 8g of amber, 11g of whole insects, 7g of centipedes, 16g of calamus calamus, and 9g of Tianzhuhuang , Dannanxing 6g, frankincense 8g, myrrh 12g, bezoar 2g, tortoise shell 9g, musk 0.5g and white snake head 9g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for treating epilepsy, a preparation and a preparation method of the medicine composition, which relate to the technical field of medicines. The medicine composition for treating epilepsy is prepared from the components in parts by weight: 7 to 12 parts of dens draconis, 7 to 12 parts of calcined oyster shell, 7 to 12 parts of concha haliotidis, 3 to7 parts of cornu saigae tataricae, 12 to 18 parts of rhizoma gastrodiae, 7 to 12 parts of batryticated silkworm, 2 to 5 parts of cinnabar, 7 to 12 parts of amber, 7 to 12 parts of scorpio, 7 to 12 parts of rhizoma arthromeris maireis, 12 to 18 parts of rhizoma acori graminei, 7 to 12 parts of concretio silicea bambusae, 3 to 7 parts of arisaema cum bile, 7 to 12 parts of frankincense, 7 to 12 parts of myrrh, 1 to 3 parts of calculus bovis, 6 to 10 parts of hawksbill sea turtle, 0.2 to 0.5 part of musk, and 5 to 10 parts of long-nosed pit viper cephalosome. The medicine composition is preparedby combining all components according to a theory of traditional Chinese medicine so as to have the effects on eliminating phlegm by cooling, removing blood stasis, dredging collaterals, calming liver wind, easing mental anxiety, calming epilepsy and relieving convulsion, and has a better treatment effect on epilepsy.

Description

technical field [0001] The invention relates to the technical field of medicine, and in particular to a pharmaceutical composition, preparation and preparation method for treating epilepsy. Background technique [0002] Epilepsy, commonly known as epilepsy, is a syndrome of chronic recurrent transient brain dysfunction. It is characterized by recurrent epileptic seizures caused by abnormal discharge of brain neurons. Epilepsy can be divided into primary and secondary according to the etiology. Primary means that the encephalopathy of such patients has no structural changes or metabolic abnormalities that can explain the symptoms, but has a close relationship with genetic factors. Secondary epilepsy is due to a variety of brain lesions and metabolic disorders, such as congenital diseases, prenatal and perinatal diseases (birth trauma is a common cause of epilepsy in infancy), sequelae of febrile convulsions, trauma, infection, poisoning , intracranial tumors, cerebrovascul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/899A61K9/48A61P25/08A61K33/28A61K35/02A61K35/10A61K35/32A61K35/413A61K35/55A61K35/583A61K35/618A61K35/64A61K35/646A61K35/648
CPCA61K9/4808A61K33/28A61K35/02A61K35/10A61K35/32A61K35/413A61K35/55A61K35/583A61K35/618A61K35/646A61K35/648A61K36/324A61K36/328A61K36/888A61K36/8884A61K36/8988A61K36/899A61K35/63A61K2300/00
Inventor 冯玉兴
Owner 冯玉兴
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com